Around 2 billion people consume alcoholic beverages worldwide, and almost 10% of the world’s population is affected by Alcohol- Use Disorders (AUDs). Alcohol consumption is responsible for approximately 3.8% of all deaths and accounts for 5.5% of the global burden of disease. So far, only three drugs [Naltrexone (NTX), Acamprosate (ACM), and Disulfiram (DF)] have been approved by the Food and Drug Administration for the treatment of alcohol dependence; however, emerging data from clinical trials suggest that these medications are relatively ineffective in maintaining the abstinence from alcohol.
Caputo F, Bernardi M. (2014). New and old drugs to treat alcohol use disorders. JOURNAL OF ALCOHOL DRUG DEPENDENCE, 2(3), ------- [10.4172/2329-6488.1000e115].
New and old drugs to treat alcohol use disorders.
BERNARDI, MAURO
2014
Abstract
Around 2 billion people consume alcoholic beverages worldwide, and almost 10% of the world’s population is affected by Alcohol- Use Disorders (AUDs). Alcohol consumption is responsible for approximately 3.8% of all deaths and accounts for 5.5% of the global burden of disease. So far, only three drugs [Naltrexone (NTX), Acamprosate (ACM), and Disulfiram (DF)] have been approved by the Food and Drug Administration for the treatment of alcohol dependence; however, emerging data from clinical trials suggest that these medications are relatively ineffective in maintaining the abstinence from alcohol.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
